EUVIMEDEUVIMED entdecken
Open Access

Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis

Grace C Pyon, Mia Y Masuda, Arina Putikova, Huijun Luo, Jessica B Gibson, Adelyn D Dao, Danna R Ortiz, Piper L Heiligenstein, James J Bonellos, William E LeSuer, Rish K Pai, Shipra Garg und 5 weitere

Journal of Allergy and Clinical Immunology · 2024

DOI: 10.1016/j.jaci.2024.08.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Grace C Pyon und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Ariz. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Interleukin-33, Mice, Transgenic, Disease Models, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: IL-33 is a type 2 inflammatory cytokine that is elevated in the esophageal epithelium of eosinophilic esophagitis (EoE) subjects. We previously developed a mouse model of EoE dependent on constitutive overexpression of IL-33 from the esophageal epithelium (EoE33). OBJECTIVE: Our objective was to develop an inducible, IL-33-dependent model of EoE and examine induction of EoE-associated pathology. METHODS: We utilized a tetracycline-inducible system to express IL-33 in the esophagus by generating 2 transgenic mice. The first (iSophagus) expresses a reverse tetracycline transactivator from the esophageal epithelium. The second (TRE33) features a tetracycline response element driving expression of IL-33. When crossed, these mice generate an inducible model of EoE (iEoE33). Mice were administered doxycycline-infused chow for up to 2 weeks. Cytokines were assessed by ELISA or bead-based multiplex analysis. T cells were assessed by flow cytometry. Pathology was assessed by histology and immunohistochemistry for IL-33, eosinophil peroxidase, CD4, and Ki-67. iEoE33 was treated with steroids and crossed with IL-13-/- mice. RESULTS: Doxycycline-treated iEoE33 mice demonstrated expression of IL-33 in the esophageal epithelium, and esophageal pathology including eosinophilia, CD4+ cell infiltrate, basal zone hyperplasia, and dilated intercellular spaces. These findings became pronounced on day 7 of induction, were accompanied by weight loss and esophageal thickening, and were steroid responsive and IL-13 dependent. CONCLUSION: Inducible IL-33 expression in the esophageal epithelium elicited features pathognomonic of EoE. iEoE33 enables investigation of EoE disease mechanisms as well as initiation, progression, and resolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisInterleukin-33Mice, TransgenicDisease Models, AnimalAnimalsMiceEsophagusEsophageal MucosaHumansInterleukin-13Mice, Knockout

Stichwörter der Autor:innen

IL-33eosinophileosinophilic esophagitistransgenetype 2 inflammation

Substanzen

Interleukin-33Il33 protein, mouseInterleukin-13

Autor:innen und Institutionen

  • Department of Medicine, Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Ariz.
  • Department of Medicine, Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Ariz; Department of Immunology, Mayo Clinic, Rochester, Minn and Mayo Clinic Arizona, Scottsdale, Ariz.
  • Division of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Ariz.
  • Division of Laboratory Medicine and Pathology, Phoenix Children's Hospital, Phoenix, Ariz.
  • Department of Medicine, Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Ariz; Division of Allergy and Immunology, Phoenix Children's Hospital, Phoenix, Ariz.
  • Division of Digestive and Liver Diseases, Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Pyon, G. C., Masuda, M. Y., Putikova, A., Luo, H., Gibson, J. B., Dao, A. D., Ortiz, D. R., Heiligenstein, P. L., Bonellos, J. J., LeSuer, W. E., Pai, R. K., Garg, S., Rank, M. A., Nakagawa, H., Kita, H., Wright, B. L., & Doyle, A. D. (2024). Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.08.026

Vancouver

Pyon GC, Masuda MY, Putikova A, Luo H, Gibson JB, Dao AD, et al. Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2024.08.026

BibTeX
@article{Pyon2024,
  author = {Pyon, Grace C and Masuda, Mia Y and Putikova, Arina and Luo, Huijun and Gibson, Jessica B and Dao, Adelyn D and Ortiz, Danna R and Heiligenstein, Piper L and Bonellos, James J and LeSuer, William E and Pai, Rish K and Garg, Shipra and Rank, Matthew A and Nakagawa, Hiroshi and Kita, Hirohito and Wright, Benjamin L and Doyle, Alfred D},
  title = {Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.jaci.2024.08.026}
}
Kostenlos starten →